John J. Kelley III Sells 1,000 Shares of Equifax Inc. (NYSE:EFX) Stock

Equifax Inc. (NYSE:EFXGet Free Report) EVP John J. Kelley III sold 1,000 shares of the firm’s stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $272.92, for a total value of $272,920.00. Following the transaction, the executive vice president now directly owns 11,269 shares in the company, valued at approximately $3,075,535.48. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Equifax Price Performance

Shares of NYSE EFX opened at $269.32 on Thursday. The company has a 50 day moving average of $291.37 and a 200 day moving average of $263.96. The company has a quick ratio of 0.79, a current ratio of 0.88 and a debt-to-equity ratio of 0.96. Equifax Inc. has a twelve month low of $164.23 and a twelve month high of $309.63. The firm has a market cap of $33.29 billion, a P/E ratio of 59.98, a PEG ratio of 2.56 and a beta of 1.58.

Equifax (NYSE:EFXGet Free Report) last released its quarterly earnings data on Wednesday, October 16th. The credit services provider reported $1.85 EPS for the quarter, beating the consensus estimate of $1.84 by $0.01. Equifax had a return on equity of 18.56% and a net margin of 10.07%. The company had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.44 billion. During the same period last year, the firm posted $1.76 earnings per share. Equifax’s revenue was up 9.3% compared to the same quarter last year. As a group, research analysts expect that Equifax Inc. will post 7.29 EPS for the current fiscal year.

Equifax Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Tuesday, September 3rd were given a dividend of $0.39 per share. The ex-dividend date of this dividend was Tuesday, September 3rd. This represents a $1.56 dividend on an annualized basis and a yield of 0.58%. Equifax’s dividend payout ratio (DPR) is 34.74%.

Institutional Investors Weigh In On Equifax

Large investors have recently added to or reduced their stakes in the stock. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in shares of Equifax by 1.1% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 292,914 shares of the credit services provider’s stock worth $78,360,000 after buying an additional 3,164 shares during the last quarter. Brookstone Capital Management grew its stake in shares of Equifax by 8.5% during the 2nd quarter. Brookstone Capital Management now owns 26,675 shares of the credit services provider’s stock valued at $6,916,000 after purchasing an additional 2,085 shares during the period. CANADA LIFE ASSURANCE Co increased its position in shares of Equifax by 14.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 126,856 shares of the credit services provider’s stock valued at $33,970,000 after purchasing an additional 15,744 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its stake in shares of Equifax by 85.8% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 37,902 shares of the credit services provider’s stock worth $9,904,000 after purchasing an additional 17,501 shares during the period. Finally, Cetera Investment Advisers grew its position in Equifax by 183.0% during the first quarter. Cetera Investment Advisers now owns 17,015 shares of the credit services provider’s stock valued at $4,552,000 after buying an additional 11,002 shares during the period. Institutional investors own 96.20% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on EFX. Citigroup boosted their target price on Equifax from $263.00 to $304.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Barclays lifted their target price on shares of Equifax from $300.00 to $380.00 and gave the company an “overweight” rating in a research note on Friday, September 13th. Wolfe Research started coverage on Equifax in a report on Tuesday, July 9th. They set an “outperform” rating and a $275.00 target price on the stock. JPMorgan Chase & Co. raised their target price on Equifax from $300.00 to $304.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Finally, Stifel Nicolaus upped their price target on Equifax from $265.00 to $305.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $310.47.

Check Out Our Latest Stock Analysis on Equifax

About Equifax

(Get Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

See Also

Insider Buying and Selling by Quarter for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.